BAJAJ BROKING

Notification
No new Notification messages
One Mobikwik Systems IPO is Open!
Apply for the One Mobikwik Systems IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
bacil pharma ltd. stock

BACIL PHARMA LTD. Share Price

60.03 -0.50 (-0.82%)
Dec 11 2024 03:15 PM Pharmaceuticals NSE: BACPHAR

BACIL PHARMA LTD. Share Price Update

As of the latest trading session, BACIL PHARMA LTD. share price is currently at 60.03, which is down by -0.50 from its previous closing. Today, the stock has fluctuated between 59.32 and 60.50. Over the past year, BACIL PHARMA LTD. has achieved a return of 1122.82 %. In the last month alone, the return has been 21.01 %. Read More...

BACIL PHARMA LTD. Performance

Day Range

Low59.32 High60.50
60.03

52 Week Range

Low 4.68 High 60.53
60.03

BACIL PHARMA LTD. Share Price

524516

BACPHAR

img img img img
No Data Available

Open Price

60.50

Prev. Close

60.53

Volume (Shares)

34163.00

Total traded value

20.49

Upper Circuit

.00

Lower Circuit

.00

Note: The current prices & values are delayed, Login to your account for live updates.

BACIL PHARMA LTD. Fundamentals


(Standalone)

Market Cap (Cr) 35.40
PE Ratio (TTM) 92.35
Book Value / Share 1.78
Beta -0.15
ROE 0.00%
EPS (TTM) 0.65
Dividend Yield 0.00%
Net Profit Qtr (Cr) 0.48

BACIL PHARMA LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.07
Net Profit 0.48
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.82
EBITDA 0.49
Effective Tax Rate (%) 0.00
Particulars JUN 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.04
Net Profit -0.03
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.06
EBITDA -0.03
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.06
Net Profit -0.04
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.07
EBITDA -0.04
Effective Tax Rate (%) 0.00
Particulars DEC 2023 (Values in Cr)
Revenue 0.00
Operating Expense 0.06
Net Profit -0.02
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.04
EBITDA -0.02
Effective Tax Rate (%) 0.00
Particulars SEP 2023 (Values in Cr)
Revenue 0.00
Operating Expense 0.04
Net Profit -0.01
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.02
EBITDA -0.01
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Book Value / Share 1.86
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.05
EBITDA Margin 0.00
Particulars MAR 2023 (Values in Cr)
Book Value / Share 1.68
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.02
EBITDA Margin 0.00
Particulars MAR 2022 (Values in Cr)
Book Value / Share 1.88
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.08
EBITDA Margin 0.00
Particulars MAR 2021 (Values in Cr)
Book Value / Share 2.13
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.13
EBITDA Margin 0.00
Particulars MAR 2020 (Values in Cr)
Book Value / Share 2.12
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.08
EBITDA Margin 0.00
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.04
Total Assets 1.32
Total Liabilities 1.32
Total Equity 1.21
Share Outstanding 5890000
Price to Book Ratio 7.87
Return on Assets (%) -4.45
Return on Capital (%) -4.5
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.02
Total Assets 1.12
Total Liabilities 1.12
Total Equity 1.09
Share Outstanding 5890000
Price to Book Ratio 3.26
Return on Assets (%) -9.03
Return on Capital (%) -9.1
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.22
Total Assets 1.27
Total Liabilities 1.27
Total Equity 1.22
Share Outstanding 5890000
Price to Book Ratio 3.05
Return on Assets (%) -303.54
Return on Capital (%) -306.94
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.09
Total Assets 4.08
Total Liabilities 4.08
Total Equity 1.39
Share Outstanding 5890000
Price to Book Ratio 1.46
Return on Assets (%) -5.85
Return on Capital (%) -15.27
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.04
Total Assets 4.10
Total Liabilities 4.10
Total Equity 1.38
Share Outstanding 5890000
Price to Book Ratio 0.78
Return on Assets (%) -7.67
Return on Capital (%) -20.27
Particulars MAR 2024 (Values in Cr)
Net Income -0.05
Cash from Operations 0.00
Cash from Investing 0.07
Cash from Financing -0.06
Net change in Cash 0.01
Free Cash Flow 0.00
Particulars MAR 2023 (Values in Cr)
Net Income -0.10
Cash from Operations -0.14
Cash from Investing -0.11
Cash from Financing 0.06
Net change in Cash -0.20
Free Cash Flow -0.14
Particulars MAR 2022 (Values in Cr)
Net Income -3.86
Cash from Operations -4.00
Cash from Investing 3.81
Cash from Financing 0.32
Net change in Cash 0.13
Free Cash Flow -4.00
Particulars MAR 2021 (Values in Cr)
Net Income -0.23
Cash from Operations -0.39
Cash from Investing 0.52
Cash from Financing -0.07
Net change in Cash 0.05
Free Cash Flow -0.39
Particulars MAR 2020 (Values in Cr)
Net Income -0.31
Cash from Operations -0.37
Cash from Investing 0.38
Cash from Financing -0.05
Net change in Cash -0.04
Free Cash Flow -0.37
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 65.90 37.87 3.59 505.01 37.54 / 77.70
BLISS GVS PHARMA LTD 155.50 19.46 1.62 1637.91 92.25 / 172.40
CIPLA LTD 1455.65 25.47 4.14 117560.12 1192.85 / 1702.00
FERMENTA BIOTECH LIMITED 414.95 144.08 4.20 1221.24 145.00 / 440.00
GLAXOSMITHKLINE PHARMA LT 2328.95 49.21 23.58 39453.82 1664.75 / 3087.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 65.90 57.30 11.20 505.01 37.54 / 77.70
AMRUTAJAN HEALTH LTD 753.60 45.84 7.31 2178.71 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6634.15 128.84 24.41 16585.38 4050.15 / 8139.85
BLISS GVS PHARMA LTD 155.50 20.27 1.59 1637.91 92.25 / 172.40

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 56.70
  • 26 Days 49.40
  • 10 Days 53.20
  • 50 Days 43.50
  • 12 Days 52.10
  • 100 Days 35.30
  • 20 Days 50.90
  • 200 Days 11.30
58.61
PIVOT
First Resistance 62.45
Second Resistance 64.37
Third Resistance 68.21
First Support 56.69
Second Support 52.85
Third Support 50.93
RSI 84.38
MACD 2.75
Commodity Channel Index (CCI) 184.16
ADX 33.47
Williams % R 0.00

Over 1 Month

down

21.01

Over 3 Months

down

175.63

Over 6 Months

down

135.70

Over 1 Year

down

1122.82

Over 3 Years

down

147.13

Over 5 Years

down

99.82

BACIL PHARMA LTD. Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

BACIL PHARMA LTD. Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
79.29
Promoter Holdings
20.7
FII
0.0
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Prakash Shah Shareholding of Promoter and Promoter Group 917930.0 15.58
Gb Hospitality (india) Pvt Ltd Public Shareholding 500000.0 8.49
Gb Logistics Commerce Ltd Public Shareholding 417300.0 7.08
Saroj Kishor Mehta Public Shareholding 165861.0 2.82
Gulechha Investment & Trading Co Pvt Ltd Shareholding of Promoter and Promoter Group 152901.0 2.6
Sanmitra Commercial Limited Shareholding of Promoter and Promoter Group 140000.0 2.38
Purshottam R Bohra Public Shareholding 108779.0 1.85
Manubhai Amrutlal Shah Public Shareholding 103000.0 1.75
Gaurang Manubhai Shah Public Shareholding 94900.0 1.61
Navin Keshrimal Mehta Public Shareholding 61801.0 1.05
Purushotam R Bohra HUF Public Shareholding 60000.0 1.02
Lal Lachhmandas Hingorani Shareholding of Promoter and Promoter Group 5000.0 0.08
Suman Shah Shareholding of Promoter and Promoter Group 1400.0 0.02
Shakuntala Shah Shareholding of Promoter and Promoter Group 900.0 0.02
Prakash Shah Huf Shareholding of Promoter and Promoter Group 1000.0 0.02
Khem Sum Apparels Overseas Ltd Shareholding of Promoter and Promoter Group 200.0 0.0

BACIL PHARMA LTD.

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About BACIL PHARMA LTD.

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by BACIL PHARMA LTD.

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Bacil Pharma Ltd?

Answer Field

The share price of Bacil Pharma Ltd for NSE is ₹ 0.00 and for BSE is ₹ 60.03.

What is the Market Cap of Bacil Pharma Ltd?

Answer Field

The market cap of Bacil Pharma Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 35.40 Cr. as of now.

What is the 52 Week High and Low of Bacil Pharma Ltd?

Answer Field

The 52 Week High and Low of Bacil Pharma Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 60.53 and ₹ 4.68.

How to Buy Bacil Pharma Ltd share?

Answer Field

You can trade in Bacil Pharma Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Bacil Pharma Ltd?

Answer Field

The 1 year returns on the stock has been 1122.82%.

What is the Current Share Price of Bacil Pharma Ltd?

Answer Field

Bacil Pharma Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 60.03 as on Dec 11 2024 03:15 PM.

What is the Market Cap of Bacil Pharma Ltd Share?

Answer Field

The market cap of Bacil Pharma Ltd for NSE ₹ 0.0 & for BSE ₹ 35.40 as on Dec 11 2024 03:15 PM.

What is the P/E Ratio of Bacil Pharma Ltd Share?

Answer Field

As on Dec 11 2024 03:15 PM the price-to-earnings (PE) ratio for Bacil Pharma Ltd share is 92.35.

What is the PB ratio of Bacil Pharma Ltd Share?

Answer Field

As on Dec 11 2024 03:15 PM, the price-to-book (PB) ratio for Bacil Pharma Ltd share is 1.78.

How to Buy Bacil Pharma Ltd Share?

Answer Field

You can trade in Bacil Pharma Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Bacil Pharma Ltd Share on Bajaj Broking App?

Answer Field

To buy Bacil Pharma Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Bacil Pharma Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text
loader